BSL Limited (NSE:BSL)
150.36
-1.64 (-1.08%)
Aug 4, 2025, 3:15 PM IST
Verve Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 81.58 | 112.33 | 169.09 | 114.79 | 13.59 | Upgrade |
Depreciation & Amortization | 175.15 | 179.93 | 108.44 | 114.86 | 120.92 | Upgrade |
Other Amortization | 3.55 | 3.49 | 0.35 | 0.31 | 0.76 | Upgrade |
Loss (Gain) From Sale of Assets | -3.65 | -2.92 | 19.09 | -2.18 | -0.23 | Upgrade |
Other Operating Activities | 315.94 | 317.13 | 171.24 | 112.58 | 161.77 | Upgrade |
Change in Accounts Receivable | 124.82 | -460.62 | -82.43 | -197.73 | -3.94 | Upgrade |
Change in Inventory | -302.61 | -247.89 | -439.88 | -253.61 | 232.95 | Upgrade |
Change in Accounts Payable | 200.58 | -213.98 | -12.72 | 269.8 | -325.45 | Upgrade |
Change in Other Net Operating Assets | -25.29 | -82.18 | 255 | -133.06 | -34.91 | Upgrade |
Operating Cash Flow | 570.07 | -394.7 | 188.18 | 25.77 | 165.46 | Upgrade |
Operating Cash Flow Growth | - | - | 630.26% | -84.43% | -42.16% | Upgrade |
Capital Expenditures | -124.19 | -225.36 | -1,671 | -160.91 | -18.67 | Upgrade |
Sale of Property, Plant & Equipment | 11.06 | 21.74 | 68.35 | 8.72 | 5.27 | Upgrade |
Investing Cash Flow | -113.13 | -203.63 | -1,602 | -152.19 | -13.4 | Upgrade |
Short-Term Debt Issued | - | 909.73 | 458.97 | 103.59 | - | Upgrade |
Long-Term Debt Issued | 155.82 | 126.8 | 1,271 | 288.34 | 219.75 | Upgrade |
Total Debt Issued | 155.82 | 1,037 | 1,730 | 391.94 | 219.75 | Upgrade |
Short-Term Debt Repaid | -96.52 | - | - | - | -148.84 | Upgrade |
Long-Term Debt Repaid | -219.12 | -121.49 | -135.24 | -140.83 | -71.8 | Upgrade |
Total Debt Repaid | -315.64 | -121.49 | -135.24 | -140.83 | -220.65 | Upgrade |
Net Debt Issued (Repaid) | -159.82 | 915.04 | 1,595 | 251.11 | -0.9 | Upgrade |
Common Dividends Paid | -10.29 | -15.44 | -12.35 | - | - | Upgrade |
Other Financing Activities | -287.01 | -301.77 | -169.32 | -123.55 | -153.38 | Upgrade |
Financing Cash Flow | -457.12 | 597.83 | 1,413 | 127.56 | -154.28 | Upgrade |
Net Cash Flow | -0.18 | -0.5 | -0.95 | 1.14 | -2.22 | Upgrade |
Free Cash Flow | 445.88 | -620.06 | -1,482 | -135.14 | 146.79 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -44.66% | Upgrade |
Free Cash Flow Margin | 6.68% | -9.30% | -31.42% | -3.10% | 4.57% | Upgrade |
Free Cash Flow Per Share | 43.32 | -60.25 | -144.03 | -13.13 | 14.26 | Upgrade |
Cash Interest Paid | 287.01 | 301.77 | 169.32 | 123.55 | 153.38 | Upgrade |
Cash Income Tax Paid | -8.77 | 11.4 | 41.58 | 43.7 | -14.4 | Upgrade |
Levered Free Cash Flow | 209.18 | -951.12 | -1,780 | -143.51 | -26.03 | Upgrade |
Unlevered Free Cash Flow | 388.56 | -762.51 | -1,674 | -66.29 | 69.83 | Upgrade |
Change in Net Working Capital | -72.51 | 1,014 | 378.4 | 198.61 | 138.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.